Plus, news about Idorsia, Enveda, Zymeworks, BerGenBio and Ignota Labs:
Harbour BioMed does another deal: The Shanghai-based biotech’s subsidiary, called HBM Alpha Therapeutics, inked a pact with an undisclosed company for up to
↧